Quick Takeaways
- This page summarizes William B. Hayes's Form 4 filing for Indaptus Therapeutics, Inc. (INDP).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 03 Oct 2022, 16:30.
William B. Hayes - 30 Sep 2022 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)
- Role
- Director
- Signature
- /s/ William B. Hayes
- Issuer symbol
- INDP
- Transactions as of
- 30 Sep 2022
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 03 Oct 2022, 16:30:12 UTC
- Previous filing
- 06 Sep 2022
- Next filing
- 05 Dec 2022
- SEC
- View on sec.gov
Quoteable Key Fact
"William B. Hayes filed Form 4 for Indaptus Therapeutics, Inc. (INDP) on 03 Oct 2022."
What Changed
- Previous filing in this sequence was filed on 06 Sep 2022.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Official SEC Source
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INDP | Stock Option (right to buy) | Award | $0 | +13,750 | $0.000000 | 13,750 | 30 Sep 2022 | Common Stock | 13,750 | $2.16 | Direct | F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The stock option vests and becomes exercisable on September 30, 2023. |